Stout Megan, Alpert Seth, Kersey Kelly, Ching Christina, Dajusta Daniel, Fuchs Molly, McLeod Daryl, Jayanthi Rama
Department of Urology, Nationwide Children's Hospital, Columbus, Ohio.
Department of Quality Improvement Services, Columbus, Ohio.
Pediatr Qual Saf. 2023 Jan 16;8(1):e623. doi: 10.1097/pq9.0000000000000623. eCollection 2023 Jan-Feb.
Pediatric patients undergoing outpatient surgeries often receive prescriptions for postoperative pain, including opioid medications. As a result, the American Academy of Pediatrics formally challenged all pediatric surgeons to decrease opioid prescribing for common specialty-specific outpatient procedures at discharge. To meet this challenge, we designed a quality improvement project to decrease the average number of opioid doses administered to pediatric patients undergoing 3 common outpatient urologic surgeries: circumcision, orchiopexy, and inguinal hernia repair (IHR).
We formally challenged providers at our institution to reduce opioid doses per prescription and administration to patients overall. We performed a retrospective chart review at our single pediatric institution to establish baseline opioid prescribing values from July 2017 to March 2018. We aimed to reduce this value by 50% in 6 months and sustain this decrease throughout the project duration.
We performed 1,518 orchiopexies, 1,505 circumcisions, and 531 IHRs. The percent change in the average number of opioid doses prescribed per patient from baseline values assessed to 2021 was statistically significant for orchiopexies ( < 0.0001), IHRs ( < 0.0001), and circumcisions ( < 0.0001). In addition, the change in the percentage of patients prescribed opioids from baseline was statistically significant for all 3 procedures ( < 0.001).
This project demonstrated that through an organized quality improvement initiative, the average number of opioid medications prescribed and the total percentage of patients prescribed opioids following common outpatient pediatric urologic procedures can be decreased by at least 50% and sustained through project duration.
接受门诊手术的儿科患者通常会收到术后疼痛的处方,包括阿片类药物。因此,美国儿科学会正式要求所有儿科外科医生减少常见专科特定门诊手术出院时的阿片类药物处方。为应对这一挑战,我们设计了一个质量改进项目,以减少接受3种常见门诊泌尿外科手术(包皮环切术、睾丸固定术和腹股沟疝修补术(IHR))的儿科患者的阿片类药物平均给药剂量。
我们正式要求本机构的医护人员减少每张处方的阿片类药物剂量以及总体给患者的用药剂量。我们在我们单一的儿科机构进行了回顾性病历审查,以确定2017年7月至2018年3月的阿片类药物处方基线值。我们的目标是在6个月内将该值降低50%,并在整个项目期间维持这一降幅。
我们进行了1518例睾丸固定术、1505例包皮环切术和531例腹股沟疝修补术。从基线值评估到2021年,每种手术每位患者的阿片类药物平均给药剂量的百分比变化在统计学上具有显著意义(睾丸固定术<0.0001,腹股沟疝修补术<0.0001,包皮环切术<0.0001)。此外,所有3种手术中开具阿片类药物的患者百分比与基线相比的变化在统计学上具有显著意义(<0.001)。
该项目表明,通过有组织的质量改进举措,常见儿科门诊泌尿外科手术后开具的阿片类药物平均数量以及开具阿片类药物的患者总百分比可降低至少50%,并在项目期间维持这一降幅。